2OW9 | Hydrolase | date | Feb 15, 2007 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Crystal Structure Analysis Of The Mmp13 Catalytic Domain In With Specific Inhibitor | ||||||||||||||
authors | A.G.Pavlovsky | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Collagenase 3 Chain: A, B Fragment: Catalytic Domain Synonym: Matrix Metalloproteinase-13, Mmp-13 Ec: 3.4.24.- Engineered: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Tissue: Cartilage Gene: Mmp13 Expression_system: Escherichia Coli Expression_system_taxid: 562 Expression_system_strain: Bl21(De3)Plyss Expression_system_vector_type: Plasmid Expression_system_plasmid: Pgemex1 | ||||||||||||||
symmetry | Space Group: C 1 2 1 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 1.74 Å | ||||||||||||
ligand | CA, HAE, SO4, SP6, ZN BindingDB | enzyme | Hydrolase E.C.3.4.24 BRENDA | ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Discovery and characterization of a novel inhibitor of matrix metalloprotease-13 (MMP13) that reduces cartilage damage in vivo without joint fibroplasia side effects., Johnson AR, Pavlovsky AG, Ortwine DF, Prior F, Man CF, Bornemeier DA, Banotai CA, Mueller WT, McConnell P, Yan C, Baragi V, Lesch C, Roark WH, Wilson M, Datta K, Guzman R, Han HK, Dyer RD, J Biol Chem. 2007 Jul 10;. PMID:17623656 |
Data retrieval |
View 2OW9 in 3D |
Visual 3D analysis of 2OW9 |
Structure-derived information |
Sequence-derived information |
Other resources with information on 2OW9 |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |